Zheng Xing Xing Ye Ri Bao·2025-10-20 08:27Market Overview - The pharmaceutical commercial sector increased by 1.19% on October 20, with Dazhenlin leading the gains [1] - The Shanghai Composite Index closed at 3863.89, up 0.63%, while the Shenzhen Component Index closed at 12813.21, up 0.98% [1] Stock Performance - Dazhenlin (603233) closed at 18.39, up 5.09%, with a trading volume of 138,100 shares and a turnover of 251 million yuan [1] - Jianfa Zhixin (301584) closed at 29.30, up 4.46%, with a trading volume of 186,400 shares and a turnover of 534 million yuan [1] - Yao Yigou (300937) closed at 27.19, up 3.74%, with a trading volume of 18,200 shares and a turnover of 4.88 million yuan [1] - Guofang Co. (600538) closed at 5.81, up 3.20%, with a trading volume of 92,900 shares and a turnover of 5.35 million yuan [1] Capital Flow - The pharmaceutical commercial sector experienced a net outflow of 11.55 million yuan from institutional funds, while retail investors saw a net inflow of 21.80 million yuan [2] - The main stocks with significant capital flow include Shanghai Pharmaceuticals (601607) with a net inflow of 16.68 million yuan from institutional funds [3] Individual Stock Capital Flow - Shanghai Pharmaceuticals (601607) had a net inflow of 16.68 million yuan from institutional funds, but a net outflow of 22.35 million yuan from retail investors [3] - Dazhenlin (603233) saw a net inflow of 11.68 million yuan from institutional funds, with a net outflow of 15.05 million yuan from retail investors [3] - Laobaixing (603883) had a net inflow of 6.98 million yuan from institutional funds, but also faced a net outflow of 1.86 million yuan from retail investors [3]